Table of Contents Author Guidelines Submit a Manuscript
Journal of Pharmaceutics
Volume 2013, Article ID 103527, 19 pages
http://dx.doi.org/10.1155/2013/103527
Review Article

Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions

1Biomedical Technology and Cell Therapy Research Laboratory, Departments of Biomedical Engineering and Physiology and Artificial Cells and Organs Research Center, Faculty of Medicine, McGill University, 3775 University Street, Montreal, QC, Canada H3A 2B4
2Faculty of Dentistry, McGill University, 3775 University Street, Montreal, QC, Canada H3A 2B4
3Department of Experimental Medicine, McGill University, 3775 University Street, Montreal, QC, Canada H3A 2B4

Received 23 July 2012; Accepted 15 October 2012

Academic Editor: Anna Wesolowska

Copyright © 2012 Catherine Tomaro-Duchesneau et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Wischke and S. P. Schwendeman, “Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles,” International Journal of Pharmaceutics, vol. 364, no. 2, pp. 298–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Prakash and T. M. S. Chang, “In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells,” International Journal of Artificial Organs, vol. 23, no. 7, pp. 429–435, 2000. View at Google Scholar · View at Scopus
  3. S. Prakash and T. M. S. Chang, “Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats,” Nature Medicine, vol. 2, no. 8, pp. 883–887, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Y. Wang, Y. T. Yu, and T. M. S. Chang, “New method for preparing more stable microcapsules for the entrapment of genetically engineered cells,” Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 33, no. 3, pp. 257–269, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Prakash, R. Coussa, C. Martoni, J. Bhathena, and A. M. Urbanska, “Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 620827, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Lin, W. Yu, X. Liu, H. Xie, W. Wang, and X. Ma, “In Vitro and in vivo characterization of alginate-chitosan-alginate artificial microcapsules for therapeutic oral delivery of live bacterial cells,” Journal of Bioscience and Bioengineering, vol. 105, no. 6, pp. 660–665, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Urbanska, J. Bhathena, and S. Prakash, “Live encapsulated Lactobacillus acidophilus cells in yogurt for therapeutic oral delivery: preparation and in vitro analysis of alginate-chitosan microcapsules,” Canadian Journal of Physiology and Pharmacology, vol. 85, no. 9, pp. 884–893, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Chow, Z. C. Liu, S. Prakash, and T. M. S. Chang, “Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal,” Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 31, no. 4, pp. 425–434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. F. A. Garofalo, M. Eng, and T. M. S. Chang, “Immobilization of P. Pictorum in open pore agar, alginate and polylysine-alginate microcapsules for serum cholesterol depletion,” Biomaterials, Artificial Cells, and Artificial Organs, vol. 17, no. 3, pp. 271–289, 1989. View at Google Scholar · View at Scopus
  10. M. L. Jones, H. Chen, W. Ouyang, T. Metz, and S. Prakash, “Microencapsulated genetically engineered Lactobacillus plantarum 80 (pCBH1) for bile acid deconjugation and its implication in lowering cholesterol,” Journal of Biomedicine and Biotechnology, vol. 2004, no. 1, pp. 61–69, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Bhathena, C. Martoni, A. Kulamarva, A. M. Urbanska, M. Malhotra, and S. Prakash, “Orally delivered microencapsulated live probiotic formulation lowers serum lipids in hypercholesterolemic hamsters,” Journal of Medicinal Food, vol. 12, no. 2, pp. 310–319, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Martoni, J. Bhathena, A. M. Urbanska, and S. Prakash, “Microencapsulated bile salt hydrolase producing Lactobacillus reuteri for oral targeted delivery in the gastrointestinal tract,” Applied Microbiology and Biotechnology, vol. 81, no. 2, pp. 225–233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. L. Jones, C. J. Martoni, M. Parent, and S. Prakash, “Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB, 30243 yoghurt formulation in hypercholesterolaemic adults,” The British Journal of Nutrition, vol. 107, no. 10, pp. 1505–1513, 2012. View at Google Scholar
  14. C. Tomaro-Duchesneau, S. Saha, M. Malhotra et al., “Probiotic ferulic acid esterase active Lactobacillus fermentum NCIMB, 5221 APA microcapsules for oral delivery: preparation and in vitro characterization,” Pharmaceuticals, vol. 5, no. 2, pp. 236–248, 2012. View at Publisher · View at Google Scholar
  15. J. Bhathena, C. Tomaro-Duchesneau, C. Martoni et al., “Effect of orally administered microencapsulated FA-producing L. fermentum on markers of metabolic syndrome: an in vivo analysis,” Journal of Diabetes & Metabolism, vol. 2, article 009, 2012. View at Google Scholar
  16. A. M. Urbanska, J. Bhathena, C. Martoni, and S. Prakash, “Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) Mice,” Digestive Diseases and Sciences, vol. 54, no. 2, pp. 264–273, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Urbanska, A. Paul, J. Bhathena, and S. Prakash, “Suppression of tumorigenesis: modulation of inflammatory cytokines by oral administration of microencapsulated probiotic yogurt formulation,” International Journal of Inflammation, vol. 2010, Article ID 894972, 2010. View at Google Scholar
  18. K. Y. Lee and T. R. Heo, “Survival of Bifidobacterium longum immobilized in calcium alginate beads in simulated gastric juices and bile salt solution,” Applied and Environmental Microbiology, vol. 66, no. 2, pp. 869–873, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. L. T. Hansen, P. M. Allan-Wojtas, Y. L. Jin, and A. T. Paulson, “Survival of Ca-alginate microencapsulated Bifidobacterium spp. in milk and simulated gastrointestinal conditions,” Food Microbiology, vol. 19, no. 1, pp. 35–45, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Ruan, H. Shi, G. Xia et al., “Encapsulated Bifidobacteria reduced bacterial translocation in rats following hemorrhagic shock and resuscitation,” Nutrition, vol. 23, no. 10, pp. 754–761, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. C. B. Fritzen-Freire, E. S. Prudencio, R. D. M. C. Amboni, S. S. Pinto, A. N. Negrao-Murakami, and F. S. Murakami, “Microencapsulation of bifidobacteria by spray drying in the presence of prebiotics,” Food Research International, vol. 45, no. 1, pp. 306–312, 2012. View at Publisher · View at Google Scholar
  22. F. Lim and A. M. Sun, “Microencapsulated islets as bioartifical endocrine pancreas,” Science, vol. 210, no. 4472, pp. 908–910, 1980. View at Google Scholar · View at Scopus
  23. G. M. O'Shea, M. F. A. Goosen, and A. M. Sun, “Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane,” Biochimica et Biophysica Acta, vol. 804, no. 1, pp. 133–136, 1984. View at Google Scholar · View at Scopus
  24. S. Darguy and G. Reach, “Immunoisolation of pancreatic B cells by microencapsulation,” Diabetologia, vol. 28, no. 10, pp. 776–780, 1985. View at Google Scholar · View at Scopus
  25. T. Kobayashi, Y. Aomatsu, H. Iwata et al., “Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression,” Transplantation, vol. 75, no. 5, pp. 619–625, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Omer, V. F. Duvivier-Kali, N. Trivedi, K. Wilmot, S. Bonner-Weir, and G. C. Weir, “Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice,” Diabetes, vol. 52, no. 1, pp. 69–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. A. G. Abalovich, M. C. Bacqué, D. Grana, and J. Milei, “Pig pancreatic islet transplantation into spontaneously diabetic dogs,” Transplantation Proceedings, vol. 41, no. 1, pp. 328–330, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. B. E. Tuch, G. W. Keogh, L. J. Williams et al., “Safety and viability of microencapsulated human islets transplanted into diabetic humans,” Diabetes Care, vol. 32, no. 10, pp. 1887–1889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. R. B. Elliott, L. Escobar, P. L. J. Tan, M. Muzina, S. Zwain, and C. Buchanan, “Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation,” Xenotransplantation, vol. 14, no. 2, pp. 157–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Calafiore, G. Basta, G. Luca et al., “Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus,” Transplantation Proceedings, vol. 38, no. 4, pp. 1156–1157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. M. Sun, Z. Cai, Z. Shi, F. Ma, and G. M. O'Shea, “Microencapsulated hepatocytes: an in vitro and in vivo study,” Biomaterials, Artificial Cells, and Artificial Organs, vol. 15, no. 2, pp. 483–496, 1987. View at Google Scholar · View at Scopus
  32. H. Wong and T. M. S. Chang, “The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice,” Biomaterials, Artificial Cells, and Artificial Organs, vol. 16, no. 4, pp. 731–739, 1988. View at Google Scholar · View at Scopus
  33. Y. Teng, Y. Wang, S. Li et al., “Treatment of acute hepatic failure in mice by transplantation of mixed microencapsulation of rat hepatocytes and transgenic human fetal liver stromal cells,” Tissue Engineering Part C, vol. 16, no. 5, pp. 1125–1134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Mei, A. Sgroi, G. Mai et al., “Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice,” Cell Transplantation, vol. 18, no. 1, pp. 101–110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. F. T. Zhang, H. J. Wan, M. H. Li et al., “Transplantation of microencapsulated umbilical-cord-bloodderived hepatic-like cells for treatment of hepatic failure,” World Journal of Gastroenterology, vol. 17, no. 7, pp. 938–945, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Zhang, S. J. Zhu, W. Wang, Y. J. Wei, and S. S. Hu, “Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function,” Gene Therapy, vol. 15, no. 1, pp. 40–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. A. H. Al Kindi, J. F. Asenjo, Y. Ge et al., “Microencapsulation to reduce mechanical loss of microspheres: implications in myocardial cell therapy,” European Journal of Cardio-thoracic Surgery, vol. 39, no. 2, pp. 241–247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Cabané, P. Gac, J. Amat et al., “Allotransplant of microencapsulated parathyroid tissue in severe postsurgical hypoparathyroidism: a case report,” Transplantation Proceedings, vol. 41, no. 9, pp. 3879–3883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Hasse, J. Schrezenmeir, B. Stinner et al., “Successful allotransplantation of microencapsulated parathyroids in rats,” World Journal of Surgery, vol. 18, no. 4, pp. 630–634, 1994. View at Google Scholar · View at Scopus
  40. C. Hasse, G. Klöck, A. Schlosser, U. Zimmermann, and M. Rothmund, “Parathyroid allotransplantation without immunosuppression,” The Lancet, vol. 350, no. 9087, pp. 1296–1297, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Rinsch, P. Dupraz, B. L. Schneider et al., “Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia,” Kidney International, vol. 62, no. 4, pp. 1395–1401, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Régulier, B. L. Schneider, N. Déglon, Y. Beuzard, and P. Aebischer, “Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts,” Gene Therapy, vol. 5, no. 8, pp. 1014–1022, 1998. View at Google Scholar · View at Scopus
  43. F. Schwenter, S. Zarei, P. Luy et al., “Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy,” Cancer Gene Therapy, vol. 18, no. 8, pp. 553–562, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. G. M. R. Vandenbossche, G. K. De Bruyne, E. A. Bruyneel et al., “Micro-encapsulation of MDCK-ras-e cells prevents loss of E-cadherin invasion-suppressor function in vivo,” International Journal of Cancer, vol. 57, no. 1, pp. 73–80, 1994. View at Google Scholar · View at Scopus
  45. H. Teng, Y. Zhang, W. Wang, X. Ma, and J. Fei, “Inhibition of tumor growth in mice by endostatin derived from abdominal transplanted encapsulated cells,” Acta Biochimica et Biophysica Sinica, vol. 39, no. 4, pp. 278–284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Zhang, W. Wang, Y. Xie et al., “In vivo culture of encapsulated endostatin-secreting Chinese hamster ovary cells for systemic tumor inhibition,” Human Gene Therapy, vol. 18, no. 5, pp. 474–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Schuch, L. Oliveira-Ferrer, S. Loges et al., “Antiangiogenic treatment with endostatin inhibits progression of AML in vivo,” Leukemia, vol. 19, no. 8, pp. 1312–1317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Joki, M. Machluf, A. Atala et al., “Continuous release of endostatin from microencapsulated engineered cells for tumor therapy,” Nature Biotechnology, vol. 19, no. 1, pp. 35–39, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Xu, L. Liu, and I. G. Charles, “Microencapsulated iNOS-expressing cells cause tumor suppression in mice,” The FASEB Journal, vol. 16, no. 2, pp. 213–215, 2002. View at Google Scholar · View at Scopus
  50. F. Afkhami, Y. Durocher, and S. Prakash, “Investigation of antiangiogenic tumor therapy potential of microencapsulated HEK293 VEGF165b producing cells,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 645610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Cirone, J. M. Bourgeois, and P. L. Chang, “Antiangiogenic cancer therapy with microencapsulated cells,” Human Gene Therapy, vol. 14, no. 11, pp. 1065–1077, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. T. A. Read, D. R. Sorensen, R. Mahesparan et al., “Local endostatin treatment of gliomas administered by microencapsulated producer cells,” Nature Biotechnology, vol. 19, no. 1, pp. 29–34, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. A. A. Li, F. Shen, T. Zhang, P. Cirone, M. Potter, and P. L. Chang, “Enhancement of myoblast microencapsulation for gene therapy,” Journal of Biomedical Materials Research Part B, vol. 77, no. 2, pp. 296–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. G. Bartsch, K. Eggert, S. Soker, C. Bokemeyer, R. Hautmann, and G. Schuch, “Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma,” Journal of Urology, vol. 179, no. 1, pp. 326–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. D. M. Moran, L. G. Koniaris, E. M. Jablonski, P. A. Cahill, C. R. Halberstad, and I. H. McKillop, “Microencapsulation of engineered cells to deliver sustained high circulating levels of interleukin-6 to study hepatocellular carcinoma progression,” Cell Transplantation, vol. 15, no. 8-9, pp. 785–798, 2006. View at Google Scholar · View at Scopus
  56. M. Shi, S. Hao, M. Quereshi, X. Guo, C. Zheng, and J. Xiang, “Significant tumor regression induced by microencapsulation of recombinant tumor cells secreting fusion protein,” Cancer Biotherapy and Radiopharmaceuticals, vol. 20, no. 3, pp. 260–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Orive, R. M. Hernandez, A. Murua et al., “Microencapsulated cells expressing VEGF for the treatment of Alzheimer's disease,” pp.S2–S5, 2007.
  58. C. V. Borlongan, S. J. M. Skinner, M. Geaney, A. V. Vasconcellos, R. B. Elliott, and D. F. Emerich, “Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke,” Stroke, vol. 35, no. 9, pp. 2206–2210, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Mesens, M. E. Rickey, and T. J. Atkins, “Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles 1,2-benzisothiazoles,” no.US7118763B2, 2006.
  60. J. M. Ramstack, P. F. Herbert, J. Strobel, and T. J. Atkins, “Preparation of biodegradable microparticles containing a biologically active agent,” vol. 08725439, no.US5650173A, 1997.
  61. J. L. Cleland, A. Lim, and M. F. Powell, “Methods and compositions for microencapsulation of adjuvants,” vol. 460, 363, no. US005643605A, 1997.
  62. D. H. Jones, G. H. Farrar, and J. C. S. Clegg, “Method of making microencapsulated DNA for vaccination and gene therapy,” vol. 09079400, no.US06270795B1, 2001.
  63. G. H. Farrar, “Microencapsulated DNA for gene therapy,” vol. 99113415.6, no. EP0965336 A1, 1999.
  64. S. H. Hyon and Y. Ikada, “Polylactic acid type microspheres containing physiologically active substance and process for preparing the same,” vol. 315, 167, no. US005100669A, 1992.
  65. B. H. Woo, S. H. Dagar, and K. Y. Yang, “Sustained-release microspheres and methods of making and using same,” vol. 11/587, 883, no.US20080131513A1, 2008.
  66. A. S. Hasan, M. Socha, A. Lamprecht et al., “Effect of the microencapsulation of nanoparticles on the reduction of burst release,” International Journal of Pharmaceutics, vol. 344, no. 1-2, pp. 53–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Illum and H. Ping, “Gastroretentive controlled release microspheres for improved drug delivery,” vol. 09/424, 145, no.US006207197B1, 2001.
  68. J. Zheng, C. Liu, D. Bao, Y. Zhao, and X. Ma, “Preparation and evaluation of floating-bioadhesive microparticles containing clarithromycin for the eradication of Helicobacter pylori,” Journal of Applied Polymer Science, vol. 102, no. 3, pp. 2226–2232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Metz, T. Haque, H. Chen, S. Prakash, D. Amre, and S. Das, “Preparation and in vitro analysis of microcapsule thalidomide formulation for targeted suppression of TNF-α,” Drug Delivery, vol. 13, no. 5, pp. 331–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Reithmeier, J. Herrmann, and A. Göpferich, “Lipid microparticles as a parenteral controlled release device for peptides,” Journal of Controlled Release, vol. 73, no. 2-3, pp. 339–350, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Deluca, G. Jiang, and B. Woo, “Poly(Acryloyl-Hydroxyethyl Starch)-PLGA Composition Microspheres,” vol.US10549760, no.US20070122487A1, 2007.
  72. M. Haghpanah, C. Marriott, and G. P. Martin, “Potential use of microencapsulation for sustained drug delivery to the respiratory tract,” Journal of Aerosol Medicine, vol. 7, no. 2, pp. 185–188, 1994. View at Google Scholar · View at Scopus
  73. A. Grenha, B. Seijo, and C. Remuñán-López, “Microencapsulated chitosan nanoparticles for lung protein delivery,” European Journal of Pharmaceutical Sciences, vol. 25, no. 4-5, pp. 427–437, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Jelvehgari, J. Barar, H. Valizadeh, and N. Heidari, “Preparation and evaluation of poly (ε-caprolactone) nanoparticles-in-microparticles by W/O/W emulsion method,” Iranian Journal of Basic Medical Sciences, vol. 13, no. 3, pp. 85–96, 2010. View at Google Scholar · View at Scopus
  75. A. Grenha, C. Remuñán-López, E. L. S. Carvalho, and B. Seijo, “Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 69, no. 1, pp. 83–93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Y. Lee, M. H. Seo, I. J. Choi, J. H. Kim, and C. M. Pai, “Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof,” vol. 09/180, 480, no.US006193994B1, 2001.
  77. H. Patel, R. Patel, and G. Patel, “Ionotropic gelation technique for microencapsulation of antihypertensive drug,” Webmed Central Pharmaceutical Sciences, vol. 1, no. 10, pp. 1–10, 2010. View at Google Scholar
  78. I. Biswal, A. Dinda, D. Das, S. Si, and K. A. Chowdary, “Encapsulation protocol for highly hydrophilic drug using non-biodegradable polymer,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, no. 2, pp. 256–259, 2011. View at Google Scholar · View at Scopus
  79. S. M. Khamanga, N. Parfitt, T. Nyamuzhiwa, H. Haidula, and R. B. Walker, “The evaluation of Eudragit microcapsules manufactured by solvent evaporation using USP Apparatus 1,” Dissolution Technologies, vol. 16, no. 2, pp. 15–22, 2009. View at Google Scholar · View at Scopus
  80. Y. Kato, H. Onishi, and Y. Machida, “Application of chitin and chitosan derivatives in the pharmaceutical field,” Current Pharmaceutical Biotechnology, vol. 4, no. 5, pp. 303–309, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. A. M. Urbanska, E. D. Karagiannis, G. Guajardo, R. S. Langer, and D. G. Anderson, “Therapeutic effect of orally administered microencapsulated oxaliplatin for colorectal cancer,” Biomaterials, vol. 33, no. 18, pp. 4752–4761, 2012. View at Publisher · View at Google Scholar
  82. M. Ahmad, A. Madni, M. Usman, A. Munir, N. Akhtar, and H. M. Shoaib Khan, “Pharmaceutical micro encapsulation technology for development of controlled release drug delivery systems,” Proceedings of World Academy of Science, Engineering and Technology, vol. 75, pp. 384–387, 2011. View at Google Scholar · View at Scopus
  83. A. Touré, H. B. Lu, X. Zhang, and X. Xueming, “Microencapsulation of ginger oil in 18DE maltodextrin/whey protein isolate,” Journal of Herbs, Spices and Medicinal Plants, vol. 17, no. 2, pp. 183–195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. W. M. Vaugn, J. E. van Hamont, and J. A. Setterstrom, “Sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres,” vol. 08/675, 895, no.US06217911B1, 2001.
  85. M. Jelvehgari, J. Barar, H. Valizadeh, B. Delf Loveymi, and M. Ziapour, “Preparation of diclofenac sodium composite microparticles with improved initial release property,” Scientia Iranica, vol. 17, no. 2, pp. 79–89, 2010. View at Google Scholar · View at Scopus
  86. Y. Y. Yang, H. H. Chia, and T. S. Chung, “Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method,” Journal of Controlled Release, vol. 69, no. 1, pp. 81–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. I. Ribeiro Dos Santos, J. Richard, B. Pech, C. Thies, and J. P. Benoit, “Microencapsulation of protein particles within lipids using a novel supercritical fluid process,” International Journal of Pharmaceutics, vol. 242, no. 1-2, pp. 69–78, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. B. Li, Z. Wujie, and Z. Pan, “A novel method for microencapsulation of protein using high-voltage electrostatic field system,” in Proceedings of the American Society of Agricultural and Biological Engineers International (ASABE '06), 2006.
  89. A. Kulamarva, P. M. V. Raja, J. Bhathena et al., “Microcapsule carbon nanotube devices for therapeutic applications,” Nanotechnology, vol. 20, no. 2, Article ID 025612, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Smith and I. M. Hunneyball, “Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration,” International Journal of Pharmaceutics, vol. 30, no. 2-3, pp. 215–220, 1986. View at Google Scholar · View at Scopus
  91. S. Ratnakar Tandale, Microencapsulation of vitamin C and gallic acid in whey protein concentrate by spray and freeze drying—characterization and degradation kinetics [M.S. thesis], 2007.
  92. Z. Ramtoola, “Controlled release biodegradable micro- and nanospheres containing cyclosporin,” vol. 479, 509, no.US005641745A, 1997.
  93. L. Brannon-Peppas, “Controlled release in the food and cosmetics industries,” in Polymeric Delivery Systems, chapter 3, pp. 42–52, American Chemical Society, 1993. View at Google Scholar
  94. P. Aebischer, S. R. Winn, and P. M. Galletti, “Transplantation of neural tissue in polymer capsules,” Brain Research, vol. 448, no. 2, pp. 364–368, 1988. View at Google Scholar · View at Scopus
  95. C. K. Colton, “Implantable biohybrid artificial organs,” Cell Transplantation, vol. 4, no. 4, pp. 415–436, 1995. View at Publisher · View at Google Scholar · View at Scopus
  96. R. Calafiore, “Alginate microcapsules for pancreatic islet cell graft immunoprotection: struggle and progress towards the final cure for type 1 diabetes mellitus,” Expert Opinion on Biological Therapy, vol. 3, no. 2, pp. 201–205, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Wikström, M. Elomaa, H. Syväjärvi et al., “Alginate-based microencapsulation of retinal pigment epithelial cell line for cell therapy,” Biomaterials, vol. 29, no. 7, pp. 869–876, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Li, O. Rouaud, and D. Poncelet, “Microencapsulation by solvent evaporation: state of the art for process engineering approaches,” International Journal of Pharmaceutics, vol. 363, no. 1-2, pp. 26–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. T. M. S. Chang, “Semipermeable microcapsules,” Science, vol. 146, no. 3643, pp. 524–525, 1964. View at Google Scholar · View at Scopus
  100. E. L. Wittbecker and P. W. Morgan, “Interfacial polycondensation. I,” Journal of Polymer Science, vol. 40, no. 137, pp. 289–297, 1959. View at Publisher · View at Google Scholar
  101. R. Arshady, “Preparation of microspheres and microcapsules by interfacial polycondensation techniques,” Journal of Microencapsulation, vol. 6, no. 1, pp. 13–28, 1989. View at Google Scholar · View at Scopus
  102. M. C. Levy, S. Lefebvre, M. Rahmouni, M. C. Andry, and M. Manfait, “Fourier transform infrared spectroscopic studies of human serum albumin microcapsules prepared by interfacial cross-linking with terephthaloylchloride: influence of polycondensation pH on spectra and relation with microcapsule morphology and size,” Journal of Pharmaceutical Sciences, vol. 80, no. 6, pp. 578–585, 1991. View at Google Scholar · View at Scopus
  103. M. C. Levy and M. C. Andry, “Microcapsules prepared through interfacial cross-linking of starch derivatives,” International Journal of Pharmaceutics, vol. 62, no. 1, pp. 27–35, 1990. View at Publisher · View at Google Scholar · View at Scopus
  104. E. N. Brown, M. R. Kessler, N. R. Sottos, and S. R. White, “In situ poly(urea-formaldehyde) microencapsulation of dicyclopentadiene,” Journal of Microencapsulation, vol. 20, no. 6, pp. 719–730, 2003. View at Publisher · View at Google Scholar · View at Scopus
  105. H. Mok and T. G. Park, “Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 70, no. 1, pp. 137–144, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. E. Teunou and D. Poncelet, “Batch and continuous fluid bed coating—review and state of the art,” Journal of Food Engineering, vol. 53, no. 4, pp. 325–340, 2002. View at Publisher · View at Google Scholar · View at Scopus
  107. M. N. Singh, K. S. Y. Hemant, M. Ram, and H. G. Shivakumar, “Microencapsulation: a promising technique for controlled drug delivery,” Journal of Research in Pharmaceutical Sciences, vol. 5, no. 2, pp. 65–77, 2010. View at Google Scholar · View at Scopus
  108. R. Dreu, M. Lustrik, M. Perpar, I. Zun, and S. Srcic, “Fluid-bed coater modifications and study of their influence on the coating process of pellets,” Drug Development and Industrial Pharmacy, vol. 38, no. 4, pp. 501–511, 2012. View at Publisher · View at Google Scholar
  109. R. Arshady, “Microcapsules for food,” Journal of Microencapsulation, vol. 10, no. 4, pp. 413–435, 1993. View at Google Scholar · View at Scopus
  110. Y. Senuma, C. Lowe, Y. Zweifel, J. G. Hilborn, and I. Marison, “Alginate hydrogel microspheres and microcapsules prepared by spinning disk atomization,” Biotechnology and Bioengineering, vol. 67, no. 5, pp. 616–622, 2000. View at Google Scholar
  111. M. Whelehan and I. W. Marison, “Microencapsulation using vibrating technology,” Journal of Microencapsulation, vol. 28, no. 8, pp. 669–688, 2012. View at Google Scholar
  112. P. A. Haas, “Formation of uniform liquid drops by application of vibration to laminar jets,” Industrial and Engineering Chemistry Research, vol. 31, no. 3, pp. 959–967, 1992. View at Google Scholar · View at Scopus
  113. J. S. Patil, M. V. Kamalapur, S. C. Marapur, and D. V. Kadam, “Ionotropic gelation and polyelectrolyte complexation: the novel techniques to design hydrogel particulate sustained, modulated drug delivery system: a review,” Digest Journal of Nanomaterials and Biostructures, vol. 5, no. 1, pp. 241–248, 2010. View at Google Scholar · View at Scopus
  114. S. Prakash, C. Tomaro-Duchesneau, S. Saha, and A. Cantor, “The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 981214, 12 pages, 2011. View at Publisher · View at Google Scholar
  115. T. Haque, H. Chen, W. Ouyang et al., “Investigation of a new microcapsule membrane combining alginate, chitosan, polyethylene glycol and poly-L-lysine for cell transplantation applications,” International Journal of Artificial Organs, vol. 28, no. 6, pp. 631–637, 2005. View at Google Scholar · View at Scopus
  116. H. Chen, W. Ouyang, M. Jones et al., “Preparation and characterization of novel polymeric microcapsules for live cell encapsulation and therapy,” Cell Biochemistry and Biophysics, vol. 47, no. 1, pp. 159–168, 2007. View at Google Scholar · View at Scopus
  117. Y. Ogushi, S. Sakai, and K. Kawakami, “Synthesis of enzymatically-gellable carboxymethylcellulose for biomedical applications,” Journal of Bioscience and Bioengineering, vol. 104, no. 1, pp. 30–33, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. J. I. Horinaka, K. Kani, Y. Itokawa, E. Ogawa, and Y. Shindo, “Gelation of gellan gum aqueous solutions studied by polarization modulation spectroscopy,” Biopolymers, vol. 75, no. 5, pp. 376–383, 2004. View at Publisher · View at Google Scholar · View at Scopus
  119. P. L. Madan, “Microencapsulation I. Phase separation or coacervation,” Drug Development and Industrial Pharmacy, vol. 4, no. 1, pp. 95–116, 1978. View at Publisher · View at Google Scholar
  120. B. Mohanty and H. B. Bohidar, “Systematic of alcohol-induced simple coacervation in aqueous gelatin solutions,” Biomacromolecules, vol. 4, no. 4, pp. 1080–1086, 2003. View at Publisher · View at Google Scholar · View at Scopus
  121. S. D. Yeo and E. Kiran, “Formation of polymer particles with supercritical fluids: a review,” Journal of Supercritical Fluids, vol. 34, no. 3, pp. 287–308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  122. L. Padrela, M. A. Rodrigues, S. P. Velaga, H. A. Matos, and E. G. de Azevedo, “Formation of indomethacin-saccharin cocrystals using supercritical fluid technology,” European Journal of Pharmaceutical Sciences, vol. 38, no. 1, pp. 9–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. C. Lacroix, F. Grattepanche, Y. Doleyres, and D. Bergmaier, “Immobilised cell technologies for the dairy industry,” in Applications of Cell Immobilisation Biotechnology, chapter 18, pp. 295–319, Springer, Amsterdam, The Netherlands, 2005. View at Google Scholar
  124. B. F. Gibbs, S. Kermasha, I. Alli, and C. N. Mulligan, “Encapsulation in the food industry: a review,” International Journal of Food Sciences and Nutrition, vol. 50, no. 3, pp. 213–224, 1999. View at Publisher · View at Google Scholar · View at Scopus
  125. FAO and WHO, Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, 2001.
  126. S. Prakash and T. M. S. Chang, “Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal,” Biotechnology and Bioengineering, vol. 46, no. 6, pp. 621–626, 1995. View at Publisher · View at Google Scholar · View at Scopus
  127. H. Gao, Y. Yu, B. Cai, and M. Wang, “Preparation and properties of microencapsulated genetically engineered bacteria cells for oral therapy of uremia,” Chinese Science Bulletin, vol. 49, no. 11, pp. 1117–1121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. J. W. Anderson and S. E. Gilliland, “Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans,” Journal of the American College of Nutrition, vol. 18, no. 1, pp. 43–50, 1999. View at Google Scholar · View at Scopus
  129. J. Bhathena, A. Kulamarva, C. Martoni, A. M. Urbanska, and S. Prakash, “Preparation and in vitro analysis of microencapsulated live Lactobacillus fermentum 11976 for augmentation of feruloyl esterase in the gastrointestinal tract,” Biotechnology and Applied Biochemistry, vol. 50, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  130. C. Tomaro-Duchesneau, S. Saha, M. Malhotra et al., “Lactobacillus fermentum NCIMB, 5221 has a greater ferulic acid production compared to other ferulic acid esterase producing Lactobacilli,” International Journal of Probiotics and Prebiotics, vol. 7, no. 1, pp. 23–32, 2012. View at Google Scholar
  131. Y. Teramura and H. Iwata, “Bioartificial pancreas. Microencapsulation and conformal coating of islet of Langerhans,” Advanced Drug Delivery Reviews, vol. 62, no. 7-8, pp. 827–840, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. K. J. Scanlon, “Cancer gene therapy: challenges and opportunities,” Anticancer Research, vol. 24, no. 2, pp. 501–504, 2004. View at Google Scholar · View at Scopus
  133. V. Bisceglie, “Uber die antineoplastische immunitat: heterologe Einpflanzung von Tumoren in Huhner-embryonen,” Zeitschrift für Krebsforschung, vol. 40, no. 1, pp. 122–140, 1933. View at Publisher · View at Google Scholar · View at Scopus
  134. T. L. Van Belle, K. T. Coppieters, and M. G. Von Herrath, “Type 1 diabetes: etiology, immunology, and therapeutic strategies,” Physiological Reviews, vol. 91, no. 1, pp. 79–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. A. M. J. Shapiro, J. R. T. Lakey, E. A. Ryan et al., “Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen,” New England Journal of Medicine, vol. 343, no. 4, pp. 230–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  136. B. L. Kasiske, H. A. Chakkera, T. A. Louis, and J. Z. Ma, “A meta-analysis of immunosuppression withdrawal trials in renal transplantation,” Journal of the American Society of Nephrology, vol. 11, no. 10, pp. 1910–1917, 2000. View at Google Scholar · View at Scopus
  137. M. T. Van Leeuwen, A. E. Grulich, S. P. McDonald et al., “Immunosuppression and other risk factors for lip cancer after kidney transplantation,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 2, pp. 561–569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. V. Dixit, R. Darvasi, M. Arthur, M. Brezina, K. Lewin, and G. Gitnick, “Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes,” Hepatology, vol. 12, no. 6, pp. 1342–1349, 1990. View at Publisher · View at Google Scholar · View at Scopus
  139. W. M. Lee, R. H. Squires, S. L. Nyberg, E. Doo, and J. H. Hoofnagle, “Acute liver failure: summary of a workshop,” Hepatology, vol. 47, no. 4, pp. 1401–1415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  140. W. Bernal, G. Auzinger, A. Dhawan, and J. Wendon, “Acute liver failure,” The Lancet, vol. 376, no. 9736, pp. 190–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  141. D. Van Poll, Y. Nahmias, A. Soto-Gutierrez et al., “Human immune reactivity against liver sinusoidal endothelial cells from GalTα(1,3)GalT-deficient pigs,” Cell Transplantation, vol. 19, no. 6-7, pp. 783–789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  142. J. C. Gerlach, K. Zeilinger, and J. F. Patzer, “Bioartificial liver systems: why, what, whither?” Regenerative Medicine, vol. 3, no. 4, pp. 575–595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  143. G. M. Abouna, “Organ shortage crisis: problems and possible solutions,” Transplantation Proceedings, vol. 40, no. 1, pp. 34–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  144. M. Vivarelli, A. Dazzi, M. Zanello et al., “Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma,” Transplantation, vol. 89, no. 2, pp. 227–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. J. P. Duffy, J. C. Hong, D. G. Farmer et al., “Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients,” Journal of the American College of Surgeons, vol. 208, no. 5, pp. 896–903, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. F. Smets, M. Najimi, and E. M. Sokal, “Cell transplantation in the treatment of liver diseases,” Pediatric Transplantation, vol. 12, no. 1, pp. 6–13, 2008. View at Publisher · View at Google Scholar · View at Scopus
  147. J. Xi, Y. Wang, P. Zhang et al., “Human fetal liver stromal cells that overexpress bFGF support growth and maintenance of human embryonic stem cells,” PLoS ONE, vol. 5, no. 12, Article ID e14457, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. B. S. McKay, B. Goodman, T. Falk, and S. J. Sherman, “Retinal pigment epithelial cell transplantation could provide trophic support in Parkinson's disease: results from an in vitro model system,” Experimental Neurology, vol. 201, no. 1, pp. 234–243, 2006. View at Publisher · View at Google Scholar · View at Scopus
  149. J. M. Löhr, R. Saller, B. Salmons, and W. H. Günzburg, “Microencapsulation of genetically engineered cells for cancer therapy,” Methods in Enzymology, vol. 346, article 35, pp. 603–618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  150. J. M. Anderson and M. S. Shive, “Biodegradation and biocompatibility of PLA and PLGA microspheres,” Advanced Drug Delivery Reviews, vol. 28, no. 1, pp. 5–24, 1997. View at Publisher · View at Google Scholar · View at Scopus
  151. J. Garces Garces, “Microcapsules,” no. US6818296B1, 2004.
  152. L. Illum and H. Ping, “Gastroretentive controlled release microspheres for improved drug delivery,” vol. 09424145, no. US6207197B1, 2001.
  153. O. Smidsrod and G. Skjak-Braek, “Alginate as immobilization matrix for cells,” Trends in Biotechnology, vol. 8, no. 3, pp. 71–78, 1990. View at Google Scholar · View at Scopus
  154. K. Westesen and B. Siekmann, “Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof,” vol. 757, 276, no. US005885486A, 1999.
  155. M. R. Gasco, “Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration,” vol.EP19980929383, no.EP0988031, 2003.
  156. D. Poncelet, “Microencapsulation: fundamentals, methods and applications,” in Surface Chemistry in Biomedical and Environmental Science, pp. 23–34, Springer, Amsterdam, The Netherlands, 2006. View at Google Scholar
  157. W. M. Obeidat, “Recent patents review in microencapsulation of pharmaceuticals using the emulsion solvent removal methods,” Recent Patents on Drug Delivery and Formulation, vol. 3, no. 3, pp. 178–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. M. E. Rickey, “Preparation of biodegradable, biocompatible microparticles containing a biologically active agent,” vol. 9/578717, no.US6290983, 2001.
  159. R. H. Reid, J. E. van Hamont, W. R. Brown, E. C. Boedeker, and C. Thies, “Microparticle carriers of maximal uptake capacity by both M cells and non-M cells,” vol. 242, 960, no.US005693343A, 1997.
  160. V. Babtsov, Y. Shapiro, and E. Kvitnitsky, “Method of microencapsulation,” vol. 10, 130, 529, no.US6932984, 2005.
  161. P. M. Hughes and C. Olejnik, “Delivery of a drug via subconjunctival or periocular delivery of a prodrug in a polymeric microparticle,” vol. 20040777796, no.EP1644047, 2006.
  162. A. Tan, S. Simovic, A. K. Davey, T. Rades, and C. A. Prestidge, “Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs,” Journal of Controlled Release, vol. 134, no. 1, pp. 62–70, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. G. H. Farrar, A. M. Tinsley-Bown, and D. H. Jones, “Encapsulation of bioactive agents,” vol. 09/310, 936, no.US6309569, 2003.
  164. S. Kamei, M. Yamada, and Y. Ogawa, “Method of producing sustained-release microcapsules,” vol. 562, 634, no.US005575987A, 1996.
  165. W. Wang, X. Liu, Y. Xie et al., “Microencapsulation using natural polysaccharides for drug delivery and cell implantation,” Journal of Materials Chemistry, vol. 16, no. 32, pp. 3252–3267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  166. S. Kamei, Y. Igari, and Y. Ogawa, “Sustained-release preparation,” vol. 10/127, 558, no.US007048947B2, 2006.
  167. P. Caliceti, S. Salmaso, N. Elvassore, and A. Bertucco, “Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques,” Journal of Controlled Release, vol. 94, no. 1, pp. 195–205, 2004. View at Publisher · View at Google Scholar · View at Scopus
  168. A. Romoser, D. Ritter, R. Majitha, K. E. Meissner, M. McShane, and C. M. Sayes, “Mitigation of quantum dot cytotoxicity by microencapsulation,” PLoS ONE, vol. 6, no. 7, Article ID e22079, 2011. View at Publisher · View at Google Scholar · View at Scopus
  169. X. Li, N. Anton, T. M. Ta, M. Zhao, N. Messaddeq, and T. F. Vandamme, “Microencapsulation of nanoemulsions: novel Trojan particles for bioactive lipid molecule delivery,” International Journal of Nanomedicine, vol. 6, no. 1, pp. 1313–1325, 2011. View at Google Scholar
  170. K. E. Lee, S. H. Cho, H. B. Lee, S. Y. Jeong, and S. H. Yuk, “Microencapsulation of lipid nanoparticles containing lipophilic drug,” Journal of Microencapsulation, vol. 20, no. 4, pp. 489–496, 2003. View at Publisher · View at Google Scholar · View at Scopus
  171. S. Prakash, M. Malhotra, W. Shao, C. Tomaro-Duchesneau, and S. Abbasi, “Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy,” Advanced Drug Delivery Reviews, vol. 63, no. 14-15, pp. 1340–1351, 2011. View at Google Scholar
  172. S. Prakash and A. G. Kulamarva, “Recent advances in drug delivery: potential and limitations of carbon nanotubes,” Recent Patents on Drug Delivery & Formulation, vol. 1, no. 3, pp. 214–221, 2007. View at Google Scholar · View at Scopus
  173. E. I. Paramera, S. J. Konteles, and V. T. Karathanos, “Microencapsulation of curcumin in cells of Saccharomyces cerevisiae,” Food Chemistry, vol. 125, no. 3, pp. 892–902, 2011. View at Publisher · View at Google Scholar · View at Scopus
  174. G. Shi, L. Rao, H. Yu, H. Xiang, H. Yang, and R. Ji, “Stabilization and encapsulation of photosensitive resveratrol within yeast cell,” International Journal of Pharmaceutics, vol. 349, no. 1-2, pp. 83–93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  175. J. R. P. Bishop, G. Nelson, and J. Lamb, “Microencapsulation in yeast cells,” Journal of Microencapsulation, vol. 15, no. 6, pp. 761–773, 1998. View at Google Scholar · View at Scopus
  176. S. A. Hamad, S. D. Stoyanov, and V. N. Paunov, “Triggered cell release from shellac-cell composite microcapsules,” Soft Matter, vol. 8, no. 1, pp. 5069–5077, 2012. View at Publisher · View at Google Scholar
  177. A. P. Esser-Kahn, N. R. Sottos, S. R. White, and J. S. Moore, “Programmable microcapsules from self-immolative polymers,” Journal of the American Chemical Society, vol. 132, no. 30, pp. 10266–10268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  178. M. H. Lee, K. C. Hribar, T. Brugarolas, N. P. Kamat, J. A. Burdick, and D. Lee, “Harnessing interfacial phenomena to program the release properties of hollow microcapsules,” Advanced Functional Materials, vol. 22, no. 1, pp. 131–138, 2012. View at Publisher · View at Google Scholar
  179. L. Gao, J. Fei, J. Zhao, W. Cui, Y. Cui, and J. Li, “pH- and redox-responsive polysaccharide-based microcapsules with autofluorescence for biomedical applications,” Chemistry, vol. 18, no. 11, pp. 3185–3192, 2012. View at Publisher · View at Google Scholar
  180. M. Z. Ma, D. F. Cheng, J. H. Ye et al., “Microencapsulated tumor assay: evaluation of the nude mouse model of pancreatic cancer,” World Journal of Gastroenterology, vol. 18, no. 3, pp. 257–267, 2012. View at Publisher · View at Google Scholar
  181. D. S. Zaytseva-Zotova, O. O. Udartseva, E. R. Andreeva et al., “Polyelectrolyte microcapsules with entrapped multicellular tumor spheroids as a novel tool to study the effects of photodynamic therapy,” Journal of Biomedical Materials Research Part B, vol. 97, no. 2, pp. 255–262, 2011. View at Publisher · View at Google Scholar · View at Scopus